Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (181-190 of 528) with videos related to

Pageof 53
Sort By:
Journal of Clinical Medicine|June 19, 2020
Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy StrategiesSwapnil Rajurkar, Isa Mambetsariev, Rebecca Pharaon, et al.
The Journal of Biological Chemistry|July 16, 2014
Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progressionFrances E Lennon, Tamara Mirzapoiazova, Nurbek Mambetsariev, et al.
Journal of Ovarian Research|July 12, 2025
Targeting the oncoprotein RLIP as novel therapy for ovarian cancerB Madhu Krishna, Pankaj Garg, Prakash Kulkarni, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Bidirectional coupling among EMT, AXL-RB1 signaling and lineage switch drives resistance to osimertinib and worse clinical outcomes in NSCLCShreya Vashista, Ritesh Kumar Meena, Prakash Kulkarni, et al.
Journal of Ovarian Research|January 31, 2026
RLIP depletion suppresses ovarian cancer growth and metastasisB Madhu Krishna, Pankaj Garg, David Horne, et al.
International Journal of Biological Macromolecules|January 9, 2022
Co-opting disorder into order: Intrinsically disordered proteins and the early evolution of complex multicellularityPrakash Kulkarni, Amita Behal, Atish Mohanty, et al.
Advances in Cancer Research|June 29, 2020
MET receptor in oncology: From biomarker to therapeutic targetRaeva Malik, Isa Mambetsariev, Jeremy Fricke, et al.
Bioanalysis|August 16, 2023
An LC-MS/MS method for simultaneous determination of LB-100 and its active metabolite, endothall, in human plasmaYe Feng, Erminia Massarelli, Eric Forman, et al.
Cancer|May 25, 2011
An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancerFang-Yi Lo, Yi-Hung Carol Tan, Hung-Chi Cheng, et al.
Oncotarget|September 8, 2016
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancerVictoria Villaflor, Brian Won, Rebecca Nagy, et al.
Pageof 53

Showing results (181-190 of 528) with videos related to

Sort By:
Pageof 53
Journal of Clinical Medicine|June 19, 2020
Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy StrategiesSwapnil Rajurkar, Isa Mambetsariev, Rebecca Pharaon, et al.
The Journal of Biological Chemistry|July 16, 2014
Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progressionFrances E Lennon, Tamara Mirzapoiazova, Nurbek Mambetsariev, et al.
Journal of Ovarian Research|July 12, 2025
Targeting the oncoprotein RLIP as novel therapy for ovarian cancerB Madhu Krishna, Pankaj Garg, Prakash Kulkarni, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Bidirectional coupling among EMT, AXL-RB1 signaling and lineage switch drives resistance to osimertinib and worse clinical outcomes in NSCLCShreya Vashista, Ritesh Kumar Meena, Prakash Kulkarni, et al.
Journal of Ovarian Research|January 31, 2026
RLIP depletion suppresses ovarian cancer growth and metastasisB Madhu Krishna, Pankaj Garg, David Horne, et al.
International Journal of Biological Macromolecules|January 9, 2022
Co-opting disorder into order: Intrinsically disordered proteins and the early evolution of complex multicellularityPrakash Kulkarni, Amita Behal, Atish Mohanty, et al.
Advances in Cancer Research|June 29, 2020
MET receptor in oncology: From biomarker to therapeutic targetRaeva Malik, Isa Mambetsariev, Jeremy Fricke, et al.
Bioanalysis|August 16, 2023
An LC-MS/MS method for simultaneous determination of LB-100 and its active metabolite, endothall, in human plasmaYe Feng, Erminia Massarelli, Eric Forman, et al.
Cancer|May 25, 2011
An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancerFang-Yi Lo, Yi-Hung Carol Tan, Hung-Chi Cheng, et al.
Oncotarget|September 8, 2016
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancerVictoria Villaflor, Brian Won, Rebecca Nagy, et al.
Pageof 53